our review covers a highly relevant clinical topic that has not been summarised in such depth before and it provides upto-date information for clinicians (as acknowledged by Funada et al). We strongly believe, for the aforementioned reasons, that the methodological points raised by the Funada et al have no impact on the validity of our conclusions.
Reply to Satoshi Funada, Takashi Yoshioka, and Yan Luo's Letter to the Editor re: Cosimo De Nunzio, Benjamin Brucker, Thomas Bschleipfer, et al. Beyond antimuscarinics: a review of pharmacological and interventional options for overactive bladder management in men / De Nunzio, C.; Brucker, B.; Bschleipfer, T.; Cornu, J. -N.; Drake, M. J.; Fusco, F.; Gravas, S.; Oelke, M.; Peyronnet, B.; Tutolo, M.; van Koeveringe, G.; Madersbacher, S.. - In: EUROPEAN UROLOGY. - ISSN 0302-2838. - 79:5(2021), pp. e147-e148. [10.1016/j.eururo.2021.02.033]
Reply to Satoshi Funada, Takashi Yoshioka, and Yan Luo's Letter to the Editor re: Cosimo De Nunzio, Benjamin Brucker, Thomas Bschleipfer, et al. Beyond antimuscarinics: a review of pharmacological and interventional options for overactive bladder management in men
De Nunzio C.;
2021
Abstract
our review covers a highly relevant clinical topic that has not been summarised in such depth before and it provides upto-date information for clinicians (as acknowledged by Funada et al). We strongly believe, for the aforementioned reasons, that the methodological points raised by the Funada et al have no impact on the validity of our conclusions.| File | Dimensione | Formato | |
|---|---|---|---|
|
De-Nunzio_Reply-to-Satoshi_2021.pdf
solo gestori archivio
Tipologia:
Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza:
Tutti i diritti riservati (All rights reserved)
Dimensione
179.98 kB
Formato
Adobe PDF
|
179.98 kB | Adobe PDF | Contatta l'autore |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
